UK markets close in 5 hours 14 minutes
  • FTSE 100

    7,391.10
    -103.03 (-1.37%)
     
  • FTSE 250

    21,642.75
    -620.49 (-2.79%)
     
  • AIM

    1,099.59
    -32.49 (-2.87%)
     
  • GBP/EUR

    1.1928
    -0.0019 (-0.16%)
     
  • GBP/USD

    1.3507
    -0.0038 (-0.28%)
     
  • BTC-GBP

    24,953.91
    -1,716.36 (-6.44%)
     
  • CMC Crypto 200

    769.78
    +527.10 (+217.20%)
     
  • S&P 500

    4,397.94
    -84.79 (-1.89%)
     
  • DOW

    34,265.37
    -450.03 (-1.30%)
     
  • CRUDE OIL

    84.95
    -0.19 (-0.22%)
     
  • GOLD FUTURES

    1,839.30
    +7.50 (+0.41%)
     
  • NIKKEI 225

    27,588.37
    +66.11 (+0.24%)
     
  • HANG SENG

    24,656.46
    -309.09 (-1.24%)
     
  • DAX

    15,315.00
    -288.88 (-1.85%)
     
  • CAC 40

    6,936.90
    -131.69 (-1.86%)
     

Worldwide Surgical Simulation Industry to 2026 - Featuring CAE, Simulab and 3B Scientific Among Others

·5-min read

Dublin, Jan. 10, 2022 (GLOBE NEWSWIRE) -- The "Surgical Simulation Market - Forecasts from 2021 to 2026" report has been added to ResearchAndMarkets.com's offering.

The surgical simulation market is projected to grow at a CAGR of 24.95% to reach US$1,265.035 million by 2026 from US$266.041 million in 2019.

Surgical simulation is essentially a computer technology, developed to train medical practitioners. One does not require any patient or animal to perform it. The use of motion sensors and three-dimensional graphics makes the experience realistic. The user can perform the entire surgery upon the virtual organs, and it also enables the users to physically feel the tissue and the organs. It helps in minimizing the errors and lethal infection rate. It allows the trainees to commit mistakes and learn from them, without risking any life.

A major reason for the growth of this market is the increase in the number of chronic diseases.

The number of people suffering from chronic diseases is rising with time, this, in turn, fuels the need for the surgical simulator. According to the world health organization, chronic diseases (non-communicable diseases) are responsible for 71% of deaths across the world, equivalent to 41 million people dying each year. In Asian countries, chronic diseases are gradually becoming growing health of concern. According to the World Economic Forum, "One in three adults worldwide has multiple chronic conditions: cardiovascular disease alongside diabetes, depression as well as cancer, or a combination of three, four, or even five or six diseases at the same time. NCDs represent more than half the global burden of disease." with the surge of such chronic diseases worldwide, the global health care system has recognized the importance of surgical simulation.

The changing demographic transition is expected to drive the demand for this market in the forecast period.

The world is almost on the verge of a demographic milestone. The rapidly aging population, globally, needs to incorporate both, technology-driven health care system and cutting-edge teaching. According to the world health organization, "The number of people aged 65 or older is projected to grow from an estimated 524 million in 2010 to nearly 1.5 billion in 2050, with most of the increase in developing countries."

The continuously aging population is likely to challenge the health care system. This dramatic rise in the elderly population is most prominent in Asia followed by Europe. According to the Population Reference Bureau, Japan has 28 percent of the population of age 65 and above followed by Italy, Finland, and Greece. 12 percent of China's population and 16 percent of the United States population is of the age 65 and above. With the continuous aging of the population, there arises a need for technology-driven surgical simulation. With more trained surgeons across the world, the demand will be effectively met.

The rising awareness in developing countries is anticipated to fuel the growth of this market.

There lie many opportunities for the surgical simulation market in developing countries. The awareness about this training technique is rapidly rising. Many initiatives such as development programs are organized in the developing economies in order to spread awareness about the various benefits associated with surgical simulation training.

According to the World Health Organization, the annual mortality rate due to cardiovascular diseases is 17.9 million, whereas cancer claims 9.6 million lives every year. Most of the people suffering from such chronic diseases are from developing countries. World Health Organization's estimates show that 85% of these deaths take place in low-and middle-income countries. Rapid unplanned urbanization and globalization of unhealthy lifestyles are few prominent causes. It has become imperative for developing countries to adopt technology-driven health care facilities, move towards a conventional medical system and train more surgeons in order to meet the ever-growing demand for a better health care system.

Rising competition and investment is expected to boost the surgical simulation market.

Prominent key market players in the surgical simulation market include CAE Inc., Simulab Corporation, 3D Systems, Inc. MEDICAL-X, among others. These players are implementing various development strategies in order to achieve a competitive edge in the market. North America is forecasted to account for a considerable share in the surgical simulation market. The Asia-Pacific market is also projected to witness growth due to high technological developments and its aging population. Also, the number of Academic and research institutes are growing speedily due to the funding done by the government. This will lead to an increase in the adoption of surgical training and hence make surgeons more proficient.

Key Topics Covered:

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Dynamics
4.1. Market Drivers
4.2. Market Restraints
4.3. Porters Five Forces Analysis
4.3.1. Bargaining Power of End-Users
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis

5. Surgical Simulation Market Analysis, by Product
5.1. Introduction
5.2. Laparoscopic
5.3. Neurological
5.4. Gynaecological
5.5. Cardiovascular
5.6. Arthroscopic
5.7. Endoscopic
5.8. Others

6. Surgical Simulation Market Analysis, by End-User
6.1. Introduction
6.2. Hospitals
6.3. Research & Academic Institutes
6.4. Surgical Clinics
6.5. Military Organizations

7. Surgical Simulation Market Analysis, by Geography
7.1. Introduction
7.2. North America
7.2.1. USA
7.2.2. Canada
7.2.3. Mexico
7.3. South America
7.3.1. Brazil
7.3.2. Argentina
7.3.3. Others
7.4. Europe
7.4.1. Germany
7.4.2. France
7.4.3. UK
7.4.4. Others
7.5. Middle East and Africa
7.5.1. Saudi Arabia
7.5.2. UAE
7.5.3. Others
7.6. Asia Pacific
7.6.1. China
7.6.2. India
7.6.3. Japan
7.6.4. South Korea
7.6.5. Taiwan
7.6.6. Thailand
7.6.7. Indonesia
7.6.8. Others

8. Competitive Environment and Analysis
8.1. Major Players and Strategy Analysis
8.2. Emerging Players and Market Lucrativeness
8.3. Mergers, Acquisitions, Agreements, and Collaborations
8.4. Vendor Competitiveness Matrix

9. Company Profiles
9.1. CAE Inc.
9.2. Gaumard Scientific Company, Inc.
9.3. Simulab Corporation
9.4. Surgical Science Sweden AB
9.5. 3B Scientific
9.6. Simendo B.V.
9.7. 3D Systems, Inc.
9.8. VirtaMed AG
9.9. MEDICAL-X
9.10. OSSimTech

For more information about this report visit https://www.researchandmarkets.com/r/rjjdi1

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting